Prof. Huimei Zhou 周慧梅
Chief Physician, Professor
Gynecologic Oncology, Peking Union Medical College Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gynecologic benign and malignant tumors, including endometrial cancer, cervical cancer, and ovarian cancer. Expertise includes minimally invasive fertility-sparing surgery, open cytoreductive surgery, chemotherapy, targeted therapy, immunotherapy, and genetic counseling.
Dr. Zhou holds a medical doctorate and has worked at Peking Union Medical College Hospital’s Gynecologic Oncology Center for over 20 years. A student of Academician Lang Jinghe, Dr. Zhou has performed over 1,000 major surgeries and authored or co-authored eight books, including Clinical Guidelines for Obstetrics and Gynecology. Research focuses on minimally invasive surgery and molecular characteristics of ovarian clear cell carcinoma.
Professional roles
- Vice Chair, Youth Committee, Reproductive Tract Disease Diagnosis and Treatment Branch, China Association for Birth Science
- Member, Gynecologic Oncology Expert Committee, Beijing Medical Reward Foundation
- Member, Pediatric Oncology Professional Committee, Beijing Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhou Huimei). Papers usually list the name as Huimei Zhou or Zhou H.
Selected publications
42 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Gynecol Cancer, 2024 (first author): Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study. PubMed 39074931
- J Ovarian Res, 2023 (first author): Can circulating cell free DNA be a promising marker in ovarian cancer? - a genome-scale profiling study in a single institution. PubMed 36641505
- Risk Manag Healthc Policy, 2021 (senior author): Could Adjuvant Chemotherapy Improve Prognosis for Cervical Cancer Patients with Elevated Pretreatment Serum Squamous-Cell Carcinoma Antigen?. PubMed 33469394
- J Ovarian Res, 2020 (first author): Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma. PubMed 32295618
- Front Oncol, 2019 (senior author): Laparoscopic vs. Open Abdominal Radical Hysterectomy for Cervical Cancer: A Single-Institution, Propensity Score Matching Study in China. PubMed 31737563
- Int J Gynecol Cancer, 2017 (first author): Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women. PubMed 28562472
- Eur J Obstet Gynecol Reprod Biol, 2013 (senior author): Duplicated uterus and hemivaginal or hemicervical atresia with ipsilateral renal agenesis: an institutional clinical series of 52 cases. PubMed 23928479
- Eur J Obstet Gynecol Reprod Biol, 2009 (senior author): Venous malformations of the female lower genital tract. PubMed 19520486
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion